NEW YORK (GenomeWeb News) – The Beijing Genomics Institute is dramatically expanding its DNA sequencing capacity by adding fourteen new next-generation sequencers, BGI said today.

BGI said it has ordered 11 new Illumina Genome Analyzers and three Roche Genome Sequencer FLX instruments. The Institute already had six Illumina sequencers, as well as 26 3730xl sequencers from Applied Biosystems and 107 MegBACE-1000 sequencers from GE Healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.